Literature DB >> 1689664

The CD59 antigen is a structural homologue of murine Ly-6 antigens but lacks interferon inducibility.

W M Philbrick1, R G Palfree, S E Maher, M M Bridgett, S Sirlin, A L Bothwell.   

Abstract

A cDNA encoding the human leukocyte antigen CD59 has been isolated from the erythroid cell line K-562 and its identity confirmed through expression in COS cells. Northern blotting reveals three message species of approximately 800, 1400 and 2000 bases in size, which are constitutively expressed in all lymphoid, erythroid, myeloid, and neural cell types tested thus far. Southern blotting of human DNA indicates a pattern consistent with the presence of a single gene, which has been mapped to chromosome 11 by somatic cell hybrids. Also, the finding of a transcriptionally active cross-hybridizing gene in monkey cells suggests conservation of CD59 sequences among primates. Comparison of the CD59 protein sequence with those of the Ly-6E and Ly-6C antigens discloses a similarity in overall structure, including the alignment of abundant cysteine residues, hydrophobic carboxy termini and conservation of amino acids surrounding the proposed phosphatidylinositol-glycan modification site for Ly-6 molecules. Unlike Ly-6, however, CD59 expression does not appear to be inducible with interferons. This, along with its limited homology and different tissue distribution, cast doubt upon the functional equivalence of CD59 and either of the well-characterized mouse Ly-6 proteins.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1689664     DOI: 10.1002/eji.1830200113

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  13 in total

Review 1.  Characterization of the human antiporcine immune response: a prerequisite to xenotransplantation.

Authors:  A L Bothwell
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 2.  Membrane defence against complement lysis: the structure and biological properties of CD59.

Authors:  A Davies; P J Lachmann
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

3.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1990-06-25       Impact factor: 16.971

Review 4.  Membrane proteins that protect against complement lysis.

Authors:  B P Morgan; S Meri
Journal:  Springer Semin Immunopathol       Date:  1994

5.  Identification of a Naegleria fowleri membrane protein reactive with anti-human CD59 antibody.

Authors:  Angela E Fritzinger; Denise M Toney; Rebecca C MacLean; Francine Marciano-Cabral
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

6.  Structure of the CD59-encoding gene: further evidence of a relationship to murine lymphocyte antigen Ly-6 protein.

Authors:  J G Petranka; D E Fleenor; K Sykes; R E Kaufman; W F Rosse
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

7.  Expression of the glycosylphosphatidylinositol-linked complement-inhibiting protein CD59 antigen in insect cells using a baculovirus vector.

Authors:  A Davies; B P Morgan
Journal:  Biochem J       Date:  1993-11-01       Impact factor: 3.857

8.  Activation and Costimulation of Intestinal T Cells: Independent and Collaborative Involvement of CD43, OX40, and Ly-6C.

Authors:  Dina Montufar-Solis; John R Klein
Journal:  Curr Immunol Rev       Date:  2005-01

9.  Porous silicon nanocarriers for dual targeting tumor associated endothelial cells and macrophages in stroma of orthotopic human pancreatic cancers.

Authors:  Kenji Yokoi; Biana Godin; Carol J Oborn; Jenolyn F Alexander; Xuewu Liu; Isaiah J Fidler; Mauro Ferrari
Journal:  Cancer Lett       Date:  2012-09-18       Impact factor: 8.679

10.  Isolation and characterization of a membrane protein from rat erythrocytes which inhibits lysis by the membrane attack complex of rat complement.

Authors:  T R Hughes; S J Piddlesden; J D Williams; R A Harrison; B P Morgan
Journal:  Biochem J       Date:  1992-05-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.